FDA Recalls Blood Pressure Drugs Due To Cancer Risks

The FDA issued a voluntary recall of a number of drugs that are used to help control blood pressure. The drugs contain an active ingredient called valsartan, which contains an impurity, N-nitrosodimethylamine (NDMA), that’s now been linked to cancer. NDMA is considered a “probable carcinogen.”

Not all NDMA products are being pulled from shelves, however, it seems the determining factor is the amount of NDMA contained

via prepforthat FDA Recalls Blood Pressure Drugs Due To Cancer Risks

One thought on “FDA Recalls Blood Pressure Drugs Due To Cancer Risks”

Comments are closed.